Anaplastic Meningioma
📧 Sign up to get email alerts when something new happens for Anaplastic Meningioma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-12-18Clinical Trial Update: Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms [Phase 1]
Phase I trial update indicates ONC206 is being studied for recurrent and rare primary central nervous system neoplasms and the study is curr…
-
CLINICAL_TRIALS trial_result · 2025-07-02Clinical Trial Update: Pilot Study of Optune (NovoTTF-100A) for Recurrent Atypical and Anaplastic Meningioma [NA]
Clinical trial update on the Optune NovoTTF-100A device for recurrent atypical and anaplastic meningioma; the pilot study is active but not …
-
CLINICAL_TRIALS research · 2025-03-13Clinical Trial Update: Predictive Factors for Survival in Aggressive Meningiomas [NA]
This entry reports an ongoing clinical study assessing predictors of survival in aggressive meningiomas (including typical, atypical, and an…
-
CLINICAL_TRIALS trial_result · 2025-01-22Clinical Trial Update: A Trial of Pembrolizumab for Refractory Atypical and Anaplastic Meningioma [Phase 2]
Phase 2 trial of pembrolizumab for refractory atypical and anaplastic meningioma has terminated; results have been posted.
-
CLINICAL_TRIALS trial_result · 2013-06-14Clinical Trial Update: Bevacizumab in Reducing CNS Side Effects in Patients Who Have Undergone Radiation Therapy to the Brain for Primary Brain Tumor, Meningioma, or Head and Neck Cancer [Phase 2]
Phase 2 trial evaluating bevacizumab to reduce central nervous system side effects after brain radiotherapy in patients with various brain t…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.